MedPath

Phonoaudiologic Therapy Adjunct to Treatment on Patients With Obstructive Sleep Apnea

Not Applicable
Completed
Conditions
Obstructive Sleep Apnea Syndrome
Interventions
Device: Continuous Positive Airway Pressure (CPAP)
Registration Number
NCT01289405
Lead Sponsor
Associação Fundo de Incentivo à Pesquisa
Brief Summary

Objective: to evaluate the effects of a speech therapy exercises program in the treatment of Obstructive Sleep Apna Syndrome (OSAS) patients based on the clinical and polysomnography (PSG) parameters.

Methods: 80 patients with OSAS will be evaluated: men, 25-65 years old, body mass index \< 35 kg/m2 and scores of Epworth Sleepiness Scale \> 9. Patients will be divided into four groups: I: 20 patients with OSAS underwent speech therapy; II: 20 patients with OSAS underwent placebo therapy of Speech Therapy; III: 20 patients starting treatment with CPAP underwent speech therapy; IV: 20 patients starting treatment with CPAP without speech therapy or placebo. The speech therapy include isometric and isotonic exercises to improve posture, mobility and muscle tone of the soft palate, pharyngeal constrictor muscles, tip and base of tongue, cheeks and lips. Placebo therapy includes relaxation exercises and stretching neck, without therapeutic purpose. Both therapies are applied for three months, three times a day, lasting 20 minutes each session. During the treatment, the subjects will be monitored in weekly meetings, for orientation and description of the exercises and return of the fulfilled exercises diary. The subjects will also be followed at the CPAP clinic in returns after one week, a month and at the end of the study. Conduct assessments before and after treatment and after twenty one days washout, including: assessing the upper airway, anthropometric investigation of the facial skeleton and speech of Orofacial, questionnaires (Epworth Sleepiness Scale, FOSQ, General Segment and use of CPAP, WHOQOL-BREF, snoring), Psychomotor Vigilance Test and PSG.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
80
Inclusion Criteria
  • Patients with a recent diagnosis of OSAS
  • Body mass index (BMI) < 35 kg/m2
Exclusion Criteria
  • Facial malformations
  • Regular use of hypnotic medications
  • Hypothyroidism
  • Previous stroke
  • Neuromuscular disease
  • Heart failure
  • Coronary disease
  • Severe obstructive nasal disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
placebo exercicesContinuous Positive Airway Pressure (CPAP)relaxation exercises and stretching neck, without therapeutic purpose.
phonoaudiologic therapyContinuous Positive Airway Pressure (CPAP)isometric and isotonic exercises to improve posture, mobility and muscle tone of the soft palate, pharyngeal constrictor muscles, tip and base of tongue, cheeks and lips.
Primary Outcome Measures
NameTimeMethod
objective sleep pattern90 days

sleep stages, arousals, apnea-hypopnea index, oxyhemoglobin saturation evaluated by polysomnography

Secondary Outcome Measures
NameTimeMethod
somnolence90 days

score of Epworth Sleepiness Scale

Quality of Life90 days

score of WHOQOL-BREF and FOSQ questionnaires

Cognition90 days

Evaluations of Psychomotor Vigilance Test

Trial Locations

Locations (1)

Associação Fundo de Incentivo a Psicofarmacologia

🇧🇷

São Paulo, SP, Brazil

© Copyright 2025. All Rights Reserved by MedPath